ID

20909

Descrizione

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00426712

collegamento

https://clinicaltrials.gov/show/NCT00426712

Keywords

  1. 2017-03-27 2017-03-27 -
Caricato su

27 mars 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis B NCT00426712

Eligibility Hepatitis B NCT00426712

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
willing and able to give written informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
progressive loss of kidney function with more advanced stage 3 (gfr at least 45 ml/min) or stage 4 chronic kidney disease by national kidney foundation classification, and are expected to eventually go on hemodialysis
Descrizione

Renal function Loss Progressive | Chronic kidney disease Chronic kidney disease NKF classification | Hemodialysis Expected

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C1517945
UMLS CUI [1,3]
C0205329
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C2074730
UMLS CUI [3,1]
C0019004
UMLS CUI [3,2]
C1517001
body mass index of 31 or less
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
received previous vaccination with any hbv vaccine (1 or more doses)
Descrizione

Vaccination Hepatitis B Vaccine Dose Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2240392
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C1265611
any history of hbv infection
Descrizione

Hepatitis B

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019163
pregnant or breast-feeding, or planning a pregnancy during the study
Descrizione

Pregnancy | Breast Feeding | Pregnancy, Planned

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
has autoimmune disease
Descrizione

Autoimmune Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
diagnosis of chronic kidney failure due to autoimmune disease
Descrizione

Chronic Kidney Failure Due to Autoimmune Disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0022661
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0004364
receiving hemodialysis treatment at the time of enrollment
Descrizione

Hemodialysis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019004
received any blood products or antibodies within 3 months prior to study entry, or is likely to require blood products during the study
Descrizione

Blood product | Antibodies

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0456388
UMLS CUI [2]
C3495458
ever received an injection with dna plasmids or oligonucleotides
Descrizione

Plasmid DNA Injection | Oligonucleotides Injection

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0032136
UMLS CUI [1,2]
C1828121
UMLS CUI [2,1]
C0028953
UMLS CUI [2,2]
C1828121
received erythropoietin within 7 days prior to the first study injection
Descrizione

Erythropoietin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0014822
received vaccination with any vaccines during the 4 weeks prior to study entry
Descrizione

Vaccination Vaccine

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C0042210
received any other investigational medicinal agent during the 4 weeks prior to study entry
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230

Similar models

Eligibility Hepatitis B NCT00426712

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
willing and able to give written informed consent
boolean
C0021430 (UMLS CUI [1])
Renal function Loss Progressive | Chronic kidney disease Chronic kidney disease NKF classification | Hemodialysis Expected
Item
progressive loss of kidney function with more advanced stage 3 (gfr at least 45 ml/min) or stage 4 chronic kidney disease by national kidney foundation classification, and are expected to eventually go on hemodialysis
boolean
C0232804 (UMLS CUI [1,1])
C1517945 (UMLS CUI [1,2])
C0205329 (UMLS CUI [1,3])
C1561643 (UMLS CUI [2,1])
C2074730 (UMLS CUI [2,2])
C0019004 (UMLS CUI [3,1])
C1517001 (UMLS CUI [3,2])
Body mass index
Item
body mass index of 31 or less
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Vaccination Hepatitis B Vaccine Dose Quantity
Item
received previous vaccination with any hbv vaccine (1 or more doses)
boolean
C0042196 (UMLS CUI [1,1])
C2240392 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Hepatitis B
Item
any history of hbv infection
boolean
C0019163 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
pregnant or breast-feeding, or planning a pregnancy during the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Autoimmune Disease
Item
has autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Chronic Kidney Failure Due to Autoimmune Disease
Item
diagnosis of chronic kidney failure due to autoimmune disease
boolean
C0022661 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0004364 (UMLS CUI [1,3])
Hemodialysis
Item
receiving hemodialysis treatment at the time of enrollment
boolean
C0019004 (UMLS CUI [1])
Blood product | Antibodies
Item
received any blood products or antibodies within 3 months prior to study entry, or is likely to require blood products during the study
boolean
C0456388 (UMLS CUI [1])
C3495458 (UMLS CUI [2])
Plasmid DNA Injection | Oligonucleotides Injection
Item
ever received an injection with dna plasmids or oligonucleotides
boolean
C0032136 (UMLS CUI [1,1])
C1828121 (UMLS CUI [1,2])
C0028953 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
Erythropoietin
Item
received erythropoietin within 7 days prior to the first study injection
boolean
C0014822 (UMLS CUI [1])
Vaccination Vaccine
Item
received vaccination with any vaccines during the 4 weeks prior to study entry
boolean
C0042196 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Investigational New Drugs
Item
received any other investigational medicinal agent during the 4 weeks prior to study entry
boolean
C0013230 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial